Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abivax SA

ABVX
Current price
9.5 EUR 0 EUR (0.00%)
Last closed 9.64 EUR
ISIN FR0012333284
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 602 630 729 EUR
Yield for 12 month +3.37 %
1Y
3Y
5Y
10Y
15Y
ABVX
21.11.2021 - 28.11.2021

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France. Address: 7-11 boulevard Haussmann, Paris, France, 75009

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

27.4 EUR

P/E ratio

Dividend Yield

Current Year

+4 596 090 EUR

Last Year

+4 558 295 EUR

Current Quarter

+6 749 419 EUR

Last Quarter

+2 232 898 EUR

Current Year

+3 892 901 EUR

Last Year

+4 487 677 EUR

Current Quarter

+6 176 525 EUR

Last Quarter

+1 856 936 EUR

Key Figures ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -168 956 283 EUR
Operating Margin TTM -1178.84 %
PE Ratio
Return On Assets TTM -46.69 %
PEG Ratio
Return On Equity TTM -171.46 %
Wall Street Target Price 27.4 EUR
Revenue TTM 8 982 317 EUR
Book Value 2 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 201.9 %
Dividend Yield
Gross Profit TTM 99 461 EUR
Earnings per share -3.41 EUR
Diluted Eps TTM -3.41 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ABVX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ABVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 147.7458
Price Sales TTM 67.0908
Enterprise Value EBITDA -16.4729
Price Book MRQ 2.9916

Financials ABVX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ABVX

For 52 weeks

8.08 EUR 15.34 EUR
50 Day MA 9.9 EUR
Shares Short Prior Month
200 Day MA 11.82 EUR
Short Ratio
Shares Short
Short Percent